DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Eng C, Kim TW, Bendell J. et al; IMblaze370 Investigators.
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol 2019;
20 (06) 849-861
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.